Episode 7: A Guide to Phase 1 Clinical Trial Designs episode artwork

EPISODE · Aug 8, 2025 · 8 MIN

Episode 7: A Guide to Phase 1 Clinical Trial Designs

from QCast: Data-Driven Dialogue in Drug Development · host Quanticate

In this QCast episode, join co-hosts Jullia and Tom as they break down Phase 1 clinical trial designs. You’ll learn exactly what happens in single and multiple ascending-dose stages, discover modern dose-escalation methods, and find out how food-effect, interaction and bioequivalence studies fit in. They’ll also share practical strategies for combining objectives, using adaptive protocols and cutting timelines without sacrificing data quality. Key TakeawaysPhase 1 is more than a basic safety check: it establishes pharmacokinetic and tolerability benchmarks that guide every later trial.Single ascending-dose studies map how a single dose behaves in the body, while multiple ascending-dose work reveals accumulation and longer-term durability.Adaptive escalation designs such as BOIN use real-time probability updates to find the right dose faster and with fewer volunteers.Early food-effect and drug to drug interaction trials determine prescribing instructions and label warnings before larger studies begin.Integrated protocols such as combining dose stages, meal-effect parts and interaction checks with interim review gates save time, reduce costs, and preserve trial flexibility.🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.About QuanticateFounded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode metadata supplied by the publisher feed · Published Aug 8, 2025

Embed this episode

In this QCast episode, join co-hosts Jullia and Tom as they break down Phase 1 clinical trial designs. You’ll learn exactly what happens in single and multiple ascending-dose stages, discover modern dose-escalation methods, and find out how food-effect, interaction and bioequivalence studies fit in. They’ll also share practical strategies for combining objectives, using adaptive protocols and cutting timelines without sacrificing data quality. Key Takeaways Phase 1 is more than a basic ...

Distinct summary based on available episode metadata or transcript content.

Ready to play

Episode 7: A Guide to Phase 1 Clinical Trial Designs

0:00 8:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of QCast: Data-Driven Dialogue in Drug Development?

This episode is 8 minutes long.

When was this QCast: Data-Driven Dialogue in Drug Development episode published?

This episode was published on August 8, 2025.

Can I download this QCast: Data-Driven Dialogue in Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!